IDEX CORP /DE/
No SEC Form 4 filings for $IEX in the last 30 days.
IDEX (IEX) Q2 2026 earnings call reported organic revenue growth of 5% and organic orders up 28%. HST led with 47% organic order growth and 12% organic revenue growth. Adjusted EPS was $2.32, above guidance $2.07 to $2.12, and adjusted EBITDA margin rose 70 bps. Free cash flow was $177M, liquidity over $1.1B, and $77M share repurchases. IEEPA tariff refunds added a $0.08 EPS benefit.
Indian Energy Exchange (IEX) reported July 2026 electricity traded volume of 13,527 MUs, up 7.7% year on year. Day-Ahead market average clearing price rose 19.3% to Rs 4.99/unit, and Real-Time to Rs 4.41/unit, up 15.1%. REC trading fell 56.3% to 7.11 lakh, with clearing prices around Rs 380/REC and Rs 376/REC.
IDEX (IEX) reported Q2 CY2026 revenue of $920.6M vs $905.4M estimates and adjusted EPS of $2.32 vs $2.11, with adjusted EBITDA $258.3M. CEO Eric Ashleman cited 28% organic order growth and strong Health & Science Technologies demand. Guidance: Q3 revenue $931.4M midpoint and full-year adjusted EPS $8.77 midpoint.
Over the past 7 days, alphai's AI scored 4 news stories mentioning IEX (IDEX CORP /DE/). Coverage has skewed bullish: 2 bullish, 1 neutral, and 1 bearish.
Recent IEX coverage spans earnings, sector analysis and regulation.
The call provides a fresh earnings and guidance update with quantified orders, margins, EPS, and a stated full-year outlook raise, supporting a near-term re-rate versus prior expectations.
Higher demand lifted day-ahead and real-time clearing prices, while REC volumes fell sharply, implying mixed near-term revenue and volume dynamics for IEX’s segments.
Guidance raises and strong organic orders support a near-term bullish bias, but the article frames it as earnings-call Q&A rather than a new discrete event beyond the print.
Near-term, IEX faces continued regulatory development risk because the court refused to intervene before final regulations are notified.
Raised full-year earnings and organic sales outlook after a strong Q2, supporting a near-term positive re-rating and momentum trade.
alphai scores every news story that mentions IEX with an AI model for sentiment and relevance, and aggregates insider trades from IDEX CORP /DE/'s SEC EDGAR Form 4 filings. Figures refresh continuously.
IDEX (IEX) Q2 2026 earnings call reported organic revenue growth of 5% and organic orders up 28%. HST led with 47% organic order growth and 12% organic revenue growth. Adjusted EPS was $2.32, above guidance $2.07 to $2.12, and adjusted EBITDA margin rose 70 bps. Free cash flow was $177M, liquidity over $1.1B, and $77M share repurchases. IEEPA tariff refunds added a $0.08 EPS benefit.
9 min readIndian Energy Exchange (IEX) reported July 2026 electricity traded volume of 13,527 MUs, up 7.7% year on year. Day-Ahead market average clearing price rose 19.3% to Rs 4.99/unit, and Real-Time to Rs 4.41/unit, up 15.1%. REC trading fell 56.3% to 7.11 lakh, with clearing prices around Rs 380/REC and Rs 376/REC.
2 min readIDEX (IEX) reported Q2 CY2026 revenue of $920.6M vs $905.4M estimates and adjusted EPS of $2.32 vs $2.11, with adjusted EBITDA $258.3M. CEO Eric Ashleman cited 28% organic order growth and strong Health & Science Technologies demand. Guidance: Q3 revenue $931.4M midpoint and full-year adjusted EPS $8.77 midpoint.
6 min readIndia’s Supreme Court rejected Indian Energy Exchange (IEX)’s plea to stop CERC’s market coupling regulations for power exchanges, saying it was not the right stage because the rules are not yet finalized. The Court allowed CERC to continue drafting while noting it expressed no view on merits. IEX argued coupling would reduce competition and raised conflict-of-interest concerns.
4 min readIDEX Corporation (NYSE:IEX) reported better-than-expected second-quarter earnings and revenue while raising its full-year guidance, sending the industrial technology company's shares nearly 4% higher in premarket trading on Wednesday. Adjusted earnings came in at $2.32 per share for the quarter ended June 30, exceeding the Wall Street consensus estimate of $2.11 by $0.21.
3 min readIDEX Corporation (NYSE: IEX) reported quarterly results for the three months ended June 30, 2026. The company said orders exceeded $1 billion, a record, and projected Q3 2026 organic sales growth of 5% to 7% and adjusted diluted EPS of $2.20 to $2.25. Net sales included a $14.7 million reduction from customer rebates tied to invalidated tariff refunds, and IDEX raised full-year guidance.
3 min readIDEX Corp. (IEX) reported Q2 results and raised its FY2026 outlook. For Q3, it guided adjusted EPS of $2.20 to $2.25 and organic net sales growth of about 5% to 7%. For FY2026, it now expects adjusted EPS of $8.70 to $8.85 with organic growth of 3% to 4%, versus prior $8.35 to $8.55. Shares were up about 7% premarket.
2 min readIDEX (NYSE:IEX) reported Q2 CY2026 revenue of $920.6 million, up 6.4% year on year and 1.7% above Wall Street estimates. Non-GAAP EPS was $2.32, up from $2.07, beating consensus by 9.9%. Management guided next-quarter revenue to a $931.4 million midpoint, and analysts expect full-year EPS to rise from $8.45 to $8.89.
4 min readIDEX CORP /DE/ (IEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 iex-20260630xex991.htm EX-99.1 Document For further information: TRADED: NYSE (IEX) EX-99.1 Investor Contact: Jim Giannakouros, CFA Vice President, Investor Relations (847) 313-9506 IDEX REPORTS SECOND QUARTER RESULTS Highlights (All comparisons are against the prior ye
6 min readIDEX (NYSE:IEX) will report earnings Wednesday before market hours. The company previously beat revenue expectations with $886.9M revenue, up 8.9% year over year, and it guided full-year EPS above analyst estimates. For the upcoming quarter, analysts expect revenue up 4.6% y/y. The average price target is $239.43 versus $223.81.
4 min read
